Skip to main content
XXII
NASDAQ Life Sciences

22nd Century Group Launches Highly Dilutive $6.4M ATM Offering, Dwarfing Sub-$1M Market Cap

Tom Rudovsky · Reported by Wiseek News
More coverage: Industrial
Sentiment info
Negative
Importance info
9
Price
$1.29
Mkt Cap
$988.233K
52W Low
$1.26
52W High
$489.9
52W Position info
2.4% above low
Off High info
100% below high
Rel. Volume info
59× avg
Market data snapshot near publication time

XXII is trading near its 52-week low of $1.26 (2.4% above the low) on elevated volume (59× avg).

Summary

22nd Century Group announced a new At-the-Market (ATM) offering to sell up to $6.4 million of common stock through Needham & Company, enabled by a prospectus supplement filed today. This offering comes as the company's market capitalization is below $1 million and its stock trades near a 52-week low. It follows a recent 10-K filing that expressed substantial doubt about the company's ability to continue as a going concern and previous highly dilutive capital raises, including a $1.84 million ATM offering launched in April and a $16 million preferred stock offering. The $6.4 million offering is exceptionally large relative to the company's current market capitalization, indicating extreme potential dilution for existing shareholders. This move underscores the company's urgent need for capital to fund general corporate purposes amidst severe financial distress. Traders will monitor the pace and pricing of share sales under this ATM program, as significant sales could further depress the stock price and accelerate dilution. The company's ability to secure sufficient capital without completely eroding shareholder value remains a critical concern.

At the time of this announcement, XXII was trading at $1.29 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $988.2K. The 52-week trading range was $1.26 to $489.90. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

XXII - Latest Insights

XXII
Jul 02, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.01
Real-time Price: $4.00 info
Change: -$0.0100 (-0.25%) info
Market Cap: $1.38M info
XXII
Jun 26, 2026, 4:15 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $3.93
Real-time Price: $4.00 info
Change: +$0.070 (+2%) info
Market Cap: $1.38M info
XXII
Jun 23, 2026, 5:23 PM EDT
Filing Type: DEF 14A
Importance Score:
10
Price at Filing: $4.70
Real-time Price: $4.00 info
Change: -$0.700 (-15%) info
Market Cap: $1.38M info
XXII
Jun 12, 2026, 5:15 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $6.52
Real-time Price: $4.00 info
Change: Reverse Stock Split info
Market Cap: $1.38M info
XXII
Jun 12, 2026, 5:00 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $6.51
Real-time Price: $4.00 info
Change: Reverse Stock Split info
Market Cap: $1.38M info